In vitro studies have shown that GM-CSF can increase antibody-dependent and independent cellular cytotoxicity (ADCC) [7] [8] [9] [10] mediated by monocytes directed against tumour cell lines [11] . In a prospective randomized study among BMT recipients [12] , GM-CSF administration was associated with a reduced relapse rate suggesting an improve ment of anti-leukaemic activity, Sever a I re po r ts h a ve s h own th a t G M -CS F ca n a (fee l pa rtieular T lymphocyte cytotoxic functions in vitro [13, 14] . In addition, a synergistic effect of GM-CSF with IL-2 resulting in a more pronouneed cytotoxici ty of T 1 ymphocytes and NK cells has been described [15] , These data suggested that GM-CSF may also enhance anti-leukaemic activity mediated by lymphocytes. However, monocytes appeared to up-or downregulate NK activity depending on their functional state and concentration [16, 17] ,
We studied the effect of GM-CSF on the anti-leukaemic activity mediated by NK cells and monocytes. We found that GM-CSF did not enhance anti-leukaemic activity in monocytes directly, but counteracted the inhibiting effect of monocytes on NK cells, resulting in an enhanced anti-leukaemic activity. 515 516 G. van dem Bosch et al.
M A T E R IA L S AND M E T H O D S

Isolation o f monocytes and lymphocytes
Mononuclear cells were separated from peripheral blood bufFy coats of live healthy volunteers by Percoli l '075g/ml (Pharma cia, Uppsala, Sweden) and centrifugated at 500 g/min for 20 min.
Separation of monocytes and lymphocytes from mono nuclear cells was performed by cell-scatter-monitored counter flow centrifugation élutriation (CCE), using a Curamé-3000, four-chamber-rotor (Dijkstra bv, Alkmaar, The Netherlands) as described previously [18, 19] , Different cell fractions were collected by reducing the rotor speed from 3000 to 2000 rev/m in with a constant How rate of 12ml/min (Fig. 1) , Purification was assessed by morphological analysis of M ay-Grünwald-Giemsa (MGG)-stained cytospin samples. Viability was deter mined by trypan blue dye exclusion, CD56 (Leu-19; Becton Dickinson). CD3 CD56 + was consid ered as NK population. Staining was performed using a standard method. Briefly, 100 //I of different CCE cell fractions were incubated at 4°C for 15 min with the appropriate volume of PE-and FITC-conjugated MoAbs. Remaining erythrocytes were subsequently lysed by FACS lysing reagent (Becton Dickinson) for 10 min at room temperature. After lysis, cells were washed once with PBS and flow cytometrically analysed.
Cytotoxicity
Lymphocytes, monocytes or combinations of both were incu bated with or without 500U/ml recombinant 1L-2 (Glaxo, Geneva, Switzerland) and with or without 250 ng/ml recombi nant GM-CSF (GM-CSF; Sandoz Pharma Ltd, Basel, Switzer land) in a final volume of 1 '0 ml culture medium in a humidified incubator with 5% CO2 in air at 37°C. In control experiments beads with a diameter of 10/ini (DNA Check; Coulter) were mixed with lymphocytes. After 18 h of incubation* supernatants were removed. Cells were resuspended in culture medium and used as effector cells in a 51Cr-release assay.
In order to determine the NK activity and IL-2-induced cytotoxicity a 51Cr-release assay was used with cell line K562 as target. K562 was maintained in logarithmic growth phase in culture medium in a humidified incubator with 5% CO2 in air at 37°C, Briefly, 2 x 106 target cells were labelled with 100/zCi 51Cr (NaCrO^ Amersham, Aylesbury, UK) at 37°C for Ih. After incubation, cells were washed three times with GPBS and suspended in culture medium. One hundred microlitres 51Crlabelled target cells (1 x 104) were incubated with 100/¿I effector cells in different ratios (6*25, 12*5, 25 and 50) in 96-well Ubottomed plates (Costar, Cambridge, MA) at 37°C for 3*5 h. Subsequently* plates were centrifuged and 100/d supernatant from each well were collected. Radioactivity was determined 111 a LKB gamma counter. Percentage of specific 51Cr release was calculated using the following formula: Percentage 5lCr release ™ (experimental51 Cr release-spontaneous 51Cr release)/(total 51Cr release-spontaneous 51Cr release), where the spontaneous 51 Cr release represents the release of target cells as such. The £ | total Cr release was determined in cell suspensions of target cells treated with 10 /¿I zap-oglobin (Coulter Electronics Ltd, Luton, UK).
I mm unoph en 0 typ ing o f N K effe c / ors
Immunophenotypic expression of the cytotoxic effector cell population was assessed by determination of the cytotoxicity of the MoAb in combination with RC. Cells (5 x 106/ml) were incubated in culture medium with 10/xg/ml MoAb in the presence of 1:4 v/v RC for lh. Subsequently, cells were washed, resuspended in culture medium and incubated in the presence of 500U/ml IL-2 for 18 h to enhance NK activity. Thereafter cytotoxicity was determined in a 51Cr-release assay as described, using the initial cell count in order to test the original number of cells that were responsible for NK activity.
Statistical analysis
Due to biological variation between different donor samples, percentage of specific 51Cr release was log-transformed in order to equalize the variances of the measurement error at different levels of the percentage of 51Cr release (i.e. to improve homoscedasticity).
To improve the fit of this linear model against the effector:
Monoclonal antibodies and complement
The following lgG 2a isotype-expressing and rabbit comple ment (RC)-iixing murine MoAbs were used: CD3 (WT32); CD7 (WT1); CD8 (WT 82) kindly provided by Dr W. Tax (Department of Nephrology, University Hospital Nijmegen, The Netherlands); CD4 (OKT4), purchased from American Type Culture Collection (ATCC, Rockville, MD) cell bank; CD2 (Leu-5b); CD 16 (Leu-1 lc) and CD56 (Leu-19) purchased from Becton Dickinson (Mountain View, CA). MoAbs were purified by using Staphylococcus aureus protein A coupled to Sepharose (Pharmacia Biosystems BV, Woerden, The Nether lands). Sera of 4-6-week-old New Zealand white rabbits were used as RC source. Sera of all rabbits were tested separately for specific and non-specific lysis of mouse spleen cells and human T cell lines. Sera with optimal cytotoxicity were pooled, snap frozen and stored at -70°C until use.
Adherence o f monocytes
Cells from lymphocyte fractions that were contaminated with monocytes (2200-2150 rev/mi n fractions; Fig. 1 ) were washed twice with glucose PBS (GPBS) and resuspended (2 x 106 cells/ ml) in culture medium containing RPMI 1640 medium (Flow Labs* Irvine» UK) supplemented with 10% fetal calf serum (FCS), 2mM L-glutamine (Flow Labs), lOOU/ml penicillin and 10 jug/m! streptomycin (Flow Labs) in plastic tissue culture flasks and incubated in a humidified atmosphere of 5% C 0 2 in air at 37°C for 1 h in order to allow monocytes to adhere. Afterwards, non-adherent cells were harvested by gently pipetting. The non-adherent cell population contained > 99% lymphocytes as determined in cytospin centrifuge preparations after MGG staining, with a viability >98% . The remaining adherent cells were incubated at 4°C during 30min and washed three times with GPBS. The adherent cell population contained > 85% monocytes, with a viability >95% . The adherent and non-adherent cells were resuspended (5 x 106 cells/ml) in cul ture medium and directly used as effector populations in 51Crrelease assay.
Phenotypic analysis o f lymphocyte suhpopulations
Lymphocyte subpopulations were characterized by flow cyto metric immunofluorescence analysis (Coulter Epics Elite; Coul ter Corporation, Hialeah* FL) using FITC-conjugated CD3 (UCHT1; Dakopatts, Glostrup, Denmark) and PE-conjugated target ratio (ETR), the regression of the log (51Cr release) versus redoubling of the ETR (log2 (ETR/6-25)) was studied. The influences of monocytes and GM-CSF in presence or absence of IL-2, separately, on the increase of log (5lCr release) were determined in an analysis of covariance. Therefore the ETR of 12*5 was used as representative value to compare the other respective ETRs, The addition of monocytes and GM-CSF was tested as independent class variables. Using these models the log-transformed 51Cr-release was related to the ETR as follows;
where ETR ranges from 6-25 to 50, m and g indicate monocyte and GM-CSF, respectively, ¡3 indicates the increase of the log (5ICr release) per doubling of the ETR, and//, indicates the log (5lCr release) at ETR of 12*5, monocyte fraction. Fractions that consisted of > 95% lympho cytes (2650-2300rev/min) were collected. This lymphocyte fraction contained 58% CD3* cells and 26% N K cells.
Imnnmophenotypic analysis o f the cytotoxic effector population
The remaining N K activity after elimination of varying sub-£ I populations was determined in a Cr-release assay (Fig. 2) . Pre-incubation with RC only did not influence NK activity (data not shown). Elimination of celts by CD3, CD4 and CD8 did not influence NK activity. Elimination of CD7, C D I6 and CD56 resulted in a strong reduction, whereas CD2 partly inhibited NK activity. These results showed that the effector cells consisted of CD3 CD56 1 cells, which also express CD7, CD 16 and partly CD2. Monocyte : lymphocyte ratio effect on N K activity NK activity was determined in lymphocytes from the lymph tv cyte fraction which are described in Fig. 1 . Results of one representative experiment out of three are shown in Fig. 3a . Addition of equivalent amounts of monocytes resulted in a strong inhibition of N K activity to K562. Addition of lower numbers of monocytes ( 1 : 10) did not suppress but rather stimulated N K activity. To show that the inhibiting effect was not induced by sterical hindrance by the presence of the high number of cells, equivalent amounts of inert beads of the same size as monocytes were mixed with lymphocytes. NK activity was slightly inhibited. These experiments were also repeated in the presence of four-fold excess of erythrocytes from the lymphocyte donor. No inhibition of NK activity was found (data not shown),
In order to study whether this suppressing effect was artificially induced by adding monocytes, NK activity was determined in CCE fraction 2200-2150 rev/min that contained substantial amounts of monocytes (monocyte : lymphocyte ratio of 1 : 1) before and after removing the monocytes by adherence to plastic (Fig. 3b ). Adherence resulted in a five fold reduction of monocytes. The remaining fraction showed a significant increase of N K activity which was comparable to the NK activity of lymphocyte fractions without detectable levels of monocytes ( Fig. 3a) . Addition of equal amounts of monocytes to the depleted lymphocyte population reintroduced the inhibiting effect.
Influence of GM-CSF on inhibitory effect o f monocytes on NK activity *-
As an extension of the results of the previous experiments we studied the influence of GM-CSF on suppression of NK activity in the lymphocyte fraction in the presence as well as the absence of monocytes and IL-2. The mean and standard error of log-transformed data of five donors for the different ETR levels are depicted in Fig. 4 .
Overall analysis of NK activity showed that the effect of GM-CSF was significantly different in the presence and absence of IL-2. Therefore the influence of GM-CSF on log (MCr release) under different conditions of monocytes was studied with or without IL-2 separately. Changes in ETR affected íogtrans formed values less in the presence than in the absence of IL-2 which was expressed by lower regression coefficients (/&; Table 1 ). The differences in these regression coefficients were not statistically significant in the presence or absence of IL-2, indicating that increase in NK activity with increasing ETR is comparable for each combination of additions.
Addition of monocytes with or without IL-2 inhibited NK activity significantly (P < 0*05) irrespective of the ETR (Fig, 4) . Addition of GM-CSF in the absence of monocytes did not significantly influence NK activity. Without IL-2 the inhibiting effect of NK activity by monocytes was also not a (fee ted. However, in the presence of IL-2, GM-CSF abrogated the inhibiting effect of monocytes significantly (P < 0*05), resulting in a NK activity level as achieved with the lymphocyte fraction alone. Only one donor did not completely restore this suppres sive activity. Purified monocytes showed < 10% N K activity in all combinations (data not shown).
(< :) 1995 Blackwell Science Ltd, Clinical and Experimenta! Immunology, 101:515 520 D IS C U S S IO N Treatment of bone marrow allograft recipients with GM-CSF has been shown to shorten the neutropenic phase, resulting in a lower incidence of infections after BMT [3] . Moreover, GM-CSF appeared to exert a graft versus leukaemia activity (GVL), since the relapse rate was lower in GM-CSF-treated recipients [12] . The mechanism behind this enhancement of GVL activity is at present not completely understood.
In allograft recipients GM-CSF induces a strong increase in the number of monocytes which may possess anti-leukaemic activity [20] . Previous studies have shown the influence of GM-CSF in regulating monocyte activity against tumour cell lines [21] and against leukaemia target cells [22] , Moreover, in vitro experiments revealed that GM-CSF enhances ADCC by gran ulocytes [8] , monocytes [7, 9, 10] and lymphocytes [33, 35] , Although T lymphocytes appeared not to express receptors for GM-CSF, some studies suggested that GM-CSF also potentiates proliferation of lymphocytes upon IL-2 stimulation [34] and their cytotoxic activity [35] .
Okamura et al [13] showed that NK activity was signifi cantly enhanced by GM-CSF in the presence of IL-2. This enhancement could be an indirect effect by interferon-gamma (IFN-7 ), which was produced as a result of monocyte stimula tion, that activates the cytotoxic activity of NK cells.
In the present study we examined in vitro the influence of GM-CSF on monocytes and NK cells with regard to the induction of NK activity. NK cells are tumoricidal, and their cancer-related cytotoxic potential is augmented after activation with IL-2 [23, 24] . Monocytes are able to down-regulate these IL-2-stimulated cells, depending on their functional state [25, 26] . Monocytes were obtained by Percoll gradient centrifu gation followed by CCE [19] , This method allows one to obtain highly purified monocytes that are not stimulated by the separation technique as such. These monocytes did not show cytotoxicity in the added concentrations against the NK-sensitive cell line K 562, even in the presence of GM-CSF. This may be due to the resting stage of these monocytes, in contrast to monocytes obtained by the usually applied Ficoll gradient centrifugation and adherence to plastic.
Lymphocyte fractions of CCE were used as the source of NK cells. Characterization of these fractions showed that the cells responsible for NK activity expressed CD2, CD7» CD56, and were CD3 . We found that addition of high amounts of monocytes to lymphocytes inhibited NK activity in the pre sence and absence of IL-2. Addition of comparable amounts of inert beads showed only a slight inhibition. Depletion oPT cells from the lymphocyte population did not decrease NIC activity. These results suggested that the inhibiting effect was induced by a direct functional effect of monocytes, in the used concentration.
This inhibition by monocytes was observed previously by other groups [27, 28] using lower amounts of monocytes. How ever, these monocyte populations were stimulated with lipopo lysaccharide (LPS) before addition to the target population. The discrepancy with our findings can be explained by the high amounts of monocytes we used in our experiments. These monocyte fractions are expected to contain a small number of cells already stimulated in vivo before isolation. In our hands small numbers of monocytes did not inhibit but rather stimu lated NK activity. Although present data are controversial, prostaglandin E2 (PGE2) appears to be involved in the inhibit ing effect of monocytes [29] [30] [31] , and the functional balance between IL-1 [31] and PGE2 determines whether suppression or augmentation of NK activity is involved.
GM-CSF hardly influenced NK activity both in the pre sence and absence of monocytes. However, addition of GM-CSF in the presence ofIL-2 abrogated completely the suppres sive effect of monocytes 011 NK activity in almost all donors. I11 one donor this abrogation appeared to be partial. This may be explained by a higher number of monocytes that could be stimulated in vivo before isolation. These results suggest that the anti-leukaemic activity in BMT recipients who are treated with GM-CSF may be enhanced by the abrogation of the suppressive activity of monocytes rather than by direct stimu lation of the monocytes.
In conclusion, GM-CSF does not directly influence NK cells, but indirectly affects NK activity by reversing the sup pressive activity of monocytes on NK activity against (or killing of) the NK-sensitive cell line K562.
These data suggest that NK activity and anti-leukaemic effects may be impaired in vivo by the recovery of monocytes following BMT. Preliminary data in an ongoing clinical trial demonstrated that patients treated with GM-CSF for 3 months showed no significant difference in monocyte: lymphocyte ratios [32] . These ratios were higher than 1 up to 2 months after BMT. Thus, it may be speculated that GM-CSF, in addition to accelerating monocyte recovery, potentially enhan cing cellular cytotoxicity and cytokine release, restores NK activity and hence improves the outcome after BMT. A large clinical trial is required, however, to prove this hypothesis. The precise mechanism by which GM -CSF affects NK activity remains to be elucidated. 
